🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiao X. Wei

Dana-Farber Cancer Institute

ORCID: 0000-0001-7093-0383
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial”.

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

The Lancet(2024)10.1016/s0140-6736(24)01653-2
N/A
4.3DataRank · unranked
287 citations

Daniel Castellano, Ken Herrmann, Johann S. De Bono, Neal D. Shore, Kim N. +18 more

Evolution of myeloid-mediated immunotherapy resistance in prostate cancer

Nature(2024)10.1038/s41586-024-08290-3
N/A
2.2DataRank · unranked
154 citations

Zenghua Fan, Matthew Clark, Averey Lea, Diamond Luong, Ali Setayesh +12 more

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

Molecular Oncology(2021)10.1002/1878-0261.12931
N/A
0.959DataRank · unranked
22 citations

Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino +16 more

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Nature Communications(2021)10.1038/s41467-021-21068-9
N/A
0.770DataRank · unranked
169 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +48 more

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-22-0306
N/A
0.553DataRank · unranked
39 citations

Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang +21 more

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci161858
N/A
0.529DataRank · unranked
33 citations

Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh +34 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509
N/A
0.425DataRank · unranked
16 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma

JCO Precision Oncology(2022)10.1200/po.21.00448
N/A
0.385DataRank · unranked
12 citations

Wanling Xie, Elio Adib, Walter M. Stadler, Yousef Zakharia, Aijai Alva +14 more

IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer

Endocrine Related Cancer(2023)10.1530/erc-23-0241
N/A
0.345DataRank · unranked
9 citations

Victoria Wang, Raina N. Fichorova, Bradley A. McGregor, Xiao X. Wei, Shehzad Basaria +2 more

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer

European Urology Oncology(2025)10.1016/j.euo.2024.10.014
N/A
0.306DataRank · unranked
3 citations

Caiwei Zhong, Wanling Xie, Emma Kelly, Bridget Whelpley, Katelyn Kuczmarski +13 more

Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.28.121806
N/A
0.208DataRank · unranked
3 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +47 more

Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.247
N/A
0DataRank · unranked
1 citations

Jamie M. Sperger, Marina N. Sharifi, Yue Shi, Charlotte N. Stahlfeld, Jennifer L. Schehr +9 more

Changes in bone turnover markers (BTM) and association with outcomes in patients with metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) +/- docetaxel (D) in CHAARTED (ECOG-ACRIN E3805).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.145
N/A
0DataRank · unranked
0 citations

Victoria Wang, Ole‐Petter R. Hamnvik, Yee Ming Cheung, Xiao X. Wei, Praful Ravi +3 more

Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.232
N/A
0DataRank · unranked
1 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, Kyle T. Helzer +10 more

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors

European Journal of Cancer(2021)10.1016/j.ejca.2021.07.031
N/A
0DataRank · unranked
16 citations

Sarah E. Street, Ian A. Strohbehn, Meghan Lee, Sophia H. Zhao, Nifasha Rusibamayila +16 more

Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.09.010
N/A
0DataRank · unranked
23 citations

B. Ziberi, Johanna Wirtz, Noella Bih, Michèle Moreau, C.V. Guthier +8 more